Abstract:Purpose/Objective: The objective of this research is to demonstrate the feasibility of using an ultrasonic tissue-typing technique to differentiate and potentially grade cancerous tissue inside the prostate. These studies were undertaken with the ultimate goal of localizing cancerous regions inside the prostate to guide tumor dose escalation for both IMRT and brachytherapy. Materials/Methods: Ultrasonic tissue-typing imaging reveals the physical properties of biological tissues noninvasively. Ultrasonic tissue typing using 1-D spectrum analysis has demonstrated the ability of identifying cancer-containing regions in the prostate (Feleppa 1997). Comparing the results from this ultrasonic technique to the results of prostate biopsies showed a high degree of accuracy with the area under the receiver-operating characteristic (ROC) curve of 0.85, a result superior to other known imaging methods. We have expanded the 1-D spectrum technique to 2-D to obtain 3-D distributions of microstructures using a sequence of 2-D spectrum analyses. Our 2-D spectrum technique analyzes radio-frequency ultrasonic echo signals and extracts features of the ultrasonic signals that are associated with properties of tissue microstructures. The 2-D method is capable of accurate assessment of asymmetric tissue features, which is a key factor in grading cancerous tissue, and hence overcomes the primary limitation of the original 1-D analysis. A theoretical model is developed to relate these measured spectral parameters to physical properties of tissue microstructures such as size, shape, orientation and acoustic impedance (stiffness). These parameters are: peak value of radially integrated spectral power (RISP); peak shift of RISP; 3-dB width of RISP; slope of angularly integrated spectral power (AISP); and intercept of AISP. Four patients with localized prostate cancer were enrolled in a feasibility study. In vivo 3-D prostate ultrasound radio-frequency (RF) data were acquired in a sequence of parallel scans which were 1 mm apart using a B&K Medical System Hawk with 7.5 MHz probe. The RF data were analyzed using a 2-D Fourier transform algorithm. The resulting spectral parameters were computed to quantitatively assess the prostatic tissue. Prostate needle biopsies were used as the gold standard. Results: From the theoretical model, we have derived closed form solutions that explicitly relate spectral parameters to the physical properties of internal biological tissue. Among these parameters, slope of AISP is sensitive to the size of the tissue microstructures; peak shift of RISP is sensitive to the orientation; peak value of RISP is sensitive to the concentration; 3-dB width of RISP is sensitive to the shape. In the initial study with four prostate cancer patients, we found that the 2-D spectral analysis results were consistent with the theoretical predictions in differentiating between cancerous and non-cancerous tissues, and low-grade and high-grade tumors. For example, decrease in the 3-dB width of RISP for the patient with high Gleason score could be due to the lack of symmetry or the loss of homogeneity of the prostatic tissue, which is indicative of high-grade cancer. Conclusions: Ultrasonic tissue-typing imaging using 2-D spectrum analysis method can contribute to the evaluation of physical properties of prostate tissue microstructures that can become the basis for segmenting cancer-containing regions and grading cancers inside prostate. Initial studies demonstrated the feasibility of clinically employing this ultrasonic imaging method for prostate cancer. As the radiation treatment technique advances, this localized tumor information will become indispensable for intraprostatic tumor dose escalation. We are now incorporating this ultrasonic tissue typing technique in our clinical trials of dose escalation (with IMRT and brachytherapy) for patients with localized prostate cancer.

CAN NEAR-INFRARED SPECTROSCOPY EVALUATE LOW URINARY TRACT SYMPTOMS IN BENIGN PROSTATE HYPERPLASIA: MODEL FOUNDATION

[Effect of Electrovaporization on the Prostate and Its Surrounding Tissues].

Combined low-frequency ultrasound and microbubble contrast agent for the treatment of benign prostatic hyperplasia.

Effects Of Low-Frequency Ultrasound Combined With Microbubbles On Benign Prostate Hyperplasia

Feasibility of interstitial near-infrared radiance spectroscopy platform for ex vivo canine prostate studies: optical properties extraction, hemoglobin and water concentration, and gold nanoparticles detection

Transurethral Prostatic Thermotherapy with a New Device in the Canine Prostate

Near‐infrared spectroscopy as a novel method of ex vivo bladder cancer tissue characterisation

Exploration of diagnostic biomarkers, microenvironment characteristics, and ursolic acid's therapeutic effect for benign prostate hyperplasia

Assessment of fiberoptic near-infrared raman spectroscopy for diagnosis of bladder and prostate cancer

[Near-Infrared Targeted Probe Designed for Intraoperative Imaging of Prostatic Neurovascular Bundles].

Diagnosis of bladder outlet obstruction in men using a near-infrared spectroscopy instrument as the noninvasive monitor for bladder function.

Predictive Factors for Tissue Inflammation in Patients with Benign Prostatic Hyperplasia: A Clinical Prediction Study

Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging

Diagnostic efficacy of systemic immune-inflammation biomarkers in benign prostatic hyperplasia using receiver operating characteristic and artificial neural network

Predicting surgical efficacy and diagnosing histological inflammation: the clinical significance of prostate exosome proteins in benign prostatic hyperplasia

Short-term Effect of 980/1470nm Diode Laser Technology on Benign Prostatic Hyperplasia

A correlation analysis between MRI-derived morphological characteristics of benign prostatic hyperplasia and lower urinary tract symptoms

Effect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: A pilot study in a canine model

Ultrasonic tissue-typing imaging for guiding dose escalation of prostate cancer radiotherapy

Identification of characteristic metabolic panels for different stages of prostate cancer by 1H NMR-based metabolomics analysis

Quantitative analysis of 3-D conformal MRI-guided transurethral ultrasound therapy of the prostate: theoretical simulations